Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-04-30FDA Approved: AZELASTINE HYDROCHLORIDE — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for azelastine hydrochloride submitted by Somerset Therapeutics, LLC.
-
FDA approval · 2021-04-30FDA Approved: AZELASTINE — Supplemental Application (Ascend Laboratories, LLC)
FDA approves a supplemental application for azelastine submitted by Ascend Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Effect of Sublingual Immunotherapy on Platlet factor4 Level in Children [Phase 3]
Phase 3 clinical trial update evaluating effects of sublingual immunotherapy on Platelet Factor 4 levels in children with allergic rhinitis.
-
FDA approval · 2021-04-16FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) submitted by Viatris Specialty LLC…
-
FDA approval · 2021-04-02FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add a chewable grape and bubblegum formulation of loratadine (Claritin) by Bayer HealthCare LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-03-25FDA Approved: CARBINOXAMINE MALEATE EXTENDED-RELEASE ORAL SUSPENSION — Supplemental Application (Neos Therapeutics, LP)
FDA approved a supplemental application to authorize an extended-release oral suspension formulation of carbinoxamine maleate, submitted by …
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo [Phase 4]
Phase 4 trial evaluating fluticasone propionate nasal spray versus placebo in allergic rhinitis and allergic conjunctivitis; study completed…
-
FDA approval · 2021-03-17FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Children's Allegra Allergy to update its labeling for fexofenadine HCl, marketed by Chattem,…
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Efficacy Of Bacterial Lysate In Children With Allergic Rhinitis [Phase 3]
Phase 3 trial update evaluating bacterial lysate for efficacy in children with allergic rhinitis has completed.
-
FDA approval · 2021-02-22FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA has approved a supplemental application for Singulair (montelukast) from Organon LLC.
-
FDA approval · 2021-02-18FDA Approved: OLOPATADINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application for olopatadine hydrochloride, updating an already-approved product. The appr…
-
FDA approval · 2021-02-18FDA Approved: AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved Padagis Israel Pharmaceuticals' azelastine hydrochloride and fluticasone propionate nasal spray as an original ANDA, provid…
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of Allergies [Phase 4]
Phase 4 clinical trial evaluating cooling sensation of an allergy product in adults with a history of allergies has been completed and resul…
-
FDA approval · 2021-01-29FDA Approved: MONTELUKAST — Supplemental Application (XLCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Montelukast from XLCare Pharmaceuticals Inc., approving changes to the generic product under…
-
FDA approval · 2021-01-25FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare Inc.'s montelukast sodium product under ANDA 202717.
-
FDA approval · 2021-01-11FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)
FDA approved a supplemental application for CLARITIN REDITABS (loratadine) from Bayer Healthcare LLC., enabling a new or revised indication …
-
FDA approval · 2021-01-07FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin Chewable Grape and Bubblegum (loratadine) by Bayer HealthCare LLC, adding a chewabl…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal Rhinitis [Phase 2]
Phase 2 clinical trial assessing safety, tolerability, and pharmacokinetics of multiple doses of VAK694 in adults with allergic rhinitis has…
-
FDA approval · 2020-12-07FDA Approved: CETIRIZINE HCL — Supplemental Application (AMERISOURCE BERGEN)
The FDA approved a supplemental application for cetirizine hydrochloride submitted by AmerisourceBergen.
-
FDA label_change · 2020-11-30FDA Approved: ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC (cetirizine hydrochloride) to update the product labeling.
-
FDA approval · 2020-11-25FDA Approved: AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for azelastine hydrochloride and fluticasone propionate by Apotex Corp.
-
FDA approval · 2020-11-12FDA Approved: NASAL ALLERGY — Supplemental Application (Kroger Company)
FDA approved Kroger's NASAL ALLERGY nasal spray containing triamcinolone acetonide via a supplemental application. This action updates the p…
-
FDA approval · 2020-11-10FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for montelukast sodium from Dr. Reddy's Laboratories Limited, under an ANDA.
-
FDA approval · 2020-11-10FDA Approved: CHILDRENS XYZAL ALLERGY — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for CHILDRENS XYZAL ALLERGY (levocetirizine dihydrochloride) from Chattem, Inc., expanding the l…
-
FDA approval · 2020-11-10FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium from Dr. Reddy's Laboratories Limited, granting continued approval of a gener…